Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Endocrinology · Primary Aldosteronism

Can You Have Primary Aldosteronism With Normal Potassium?

At a Glance

Yes. Primary aldosteronism can be present even when blood potassium is normal, because low potassium is not required for the condition. People with resistant or difficult-to-control hypertension should ask a clinician whether an aldosterone-to-renin ratio blood test is appropriate.

Yes, absolutely. Having a normal potassium level does not rule out primary aldosteronism (PA) [1]. In fact, the vast majority of people with this condition have completely normal potassium levels [2].

Medical research shows that up to 90% of patients with primary aldosteronism have normal potassium levels (normokalemia, meaning the amount of potassium in your blood is within the standard healthy range) [1][2]. Relying on low potassium as the main warning sign is an outdated practice that prevents many patients from getting the screening they need [1].

The “Low Potassium” Myth

Historically, primary aldosteronism was thought to be a rare condition that mainly caused severe high blood pressure and dangerous drops in potassium [3]. We now know this is a misconception [4].

While the excess aldosterone (a hormone produced by the adrenal glands that regulates salt and water balance) produced in PA can cause your kidneys to excrete too much potassium, this is not a strict rule [5][6]. Serum potassium can remain normal despite extra potassium being lost in the urine, and this depends on factors like sodium intake, kidney function, and medications [5]. For most patients, potassium levels stay in the normal range, even while the excess aldosterone increases blood pressure and can increase the risk of cardiovascular and kidney issues if untreated [7][8]. Therefore, a normal potassium test does not mean your aldosterone levels are normal [7].

A Better Indicator: Resistant Hypertension

If normal potassium doesn’t rule out primary aldosteronism, what should prompt a doctor to test for it? A much more common everyday indicator is resistant hypertension. This is generally defined as high blood pressure that remains above target levels despite taking three blood pressure medications of different classes (usually including a diuretic, or “water pill”) at maximally tolerated doses, or blood pressure that requires four or more medications to control [9].

Studies show that 20-30% of people with resistant hypertension actually have primary aldosteronism [10]. Major endocrine and hypertension guidelines state that anyone with resistant hypertension should be screened for PA, regardless of their serum potassium levels [11][9].

According to major guidelines (such as those from the Endocrine Society), you should also be screened if you have:

  • Sustained blood pressure at or above 150/100 mmHg [12]
  • High blood pressure along with sleep apnea, an adrenal nodule, or a family history of early stroke or early-onset hypertension (before age 40) [12]
  • A first-degree relative with primary aldosteronism [12]

Note on broader screening: More recent updates, such as the 2025 Endocrine Society guidelines, now suggest considering screening for primary aldosteronism in people with hypertension more broadly, not just those in high-risk groups [13].

(Note on low potassium: While low potassium isn’t required for a diagnosis, if you DO have unexplained, severely low potassium along with high blood pressure, it is a strong reason for prompt evaluation. One specialized study found that up to 88.5% of patients with spontaneous, severely low potassium (below 2.5 mmol/L) and high blood pressure had PA [14]. Severe hypokalemia can cause weakness and abnormal heart rhythms, so seek prompt medical care if you experience this.)

Getting the Right Test: The ARR

If you suspect you might have primary aldosteronism, your doctor should order an aldosterone-to-renin ratio (ARR) blood test [15][2]. This is an initial screening test that compares your aldosterone levels to renin (an enzyme produced by the kidneys that normally regulates aldosterone) [15].

Important Medication Warning: Do NOT stop or change your blood pressure medications on your own before this test. Several common blood pressure drugs can alter renin or aldosterone levels, which affects the ARR [2]. However, abruptly stopping medications can cause dangerous spikes in blood pressure. Your clinician will create an individualized, supervised plan, which may involve temporarily switching to different medications (medication washout) or interpreting the test while you remain on your current drugs [2].

Potassium and the ARR: While normal potassium is not an absolute requirement to draw your blood, having low potassium can temporarily suppress your aldosterone production, leading to a false-negative screening result [15]. For this reason, clinicians generally prefer to correct low potassium before testing, and a test done while your potassium is low may need to be repeated after it is corrected [2].

Remember that a positive ARR is a screening result, not a final diagnosis. If your ARR is elevated, your clinician will review the specific aldosterone and renin values, consider your medications and potassium levels, and likely recommend confirmatory testing to establish a definitive diagnosis [15][16].

Common questions in this guide

Can primary aldosteronism occur if my potassium is normal?
Yes. Up to about 90% of people with primary aldosteronism have potassium in the normal range, so a normal result does not rule out the condition.
When should I ask about screening for primary aldosteronism?
Ask about screening if your blood pressure remains high despite three medications, if it requires four or more medicines, or if you have sustained readings of 150/100 mmHg or higher. Screening may also be appropriate with sleep apnea, an adrenal nodule, a first-degree relative with primary aldosteronism, or a family history of early stroke or early-onset hypertension.
What blood test is used to screen for primary aldosteronism?
The usual initial screen is the aldosterone-to-renin ratio, a blood test comparing aldosterone with renin. A high ratio is not by itself a final diagnosis; your clinician may review medication and potassium effects and order confirmatory testing.
Can my blood pressure medicines affect the aldosterone-to-renin ratio?
Yes. Several blood pressure medicines can change renin or aldosterone and affect the ratio, but stopping them suddenly can be dangerous. Your clinician should decide whether to adjust, switch, or interpret your medicines during testing.
Does low potassium affect primary aldosteronism testing?
Yes. Low potassium can temporarily lower aldosterone and produce a falsely reassuring screening result. Clinicians generally correct low potassium before testing and may repeat the test afterward.

Get notified when new evidence is published on hyperaldosteronism.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    Hypokalemia and the Prevalence of Primary Aldosteronism.

    Gruber S, Beuschlein F

    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2020; (52(6)):347-356 doi:10.1055/a-1134-4980.

    PMID: 32252108
  2. 2

    What We Know about and What Is New in Primary Aldosteronism.

    Ekman N, Grossman AB, Dworakowska D

    International journal of molecular sciences 2024; (25(2)) doi:10.3390/ijms25020900.

    PMID: 38255973
  3. 3

    Primary aldosteronism in the primary care setting.

    Buffolo F, Monticone S, Tetti M, Mulatero P

    Current opinion in endocrinology, diabetes, and obesity 2018; (25(3)):155-159 doi:10.1097/MED.0000000000000408.

    PMID: 29629943
  4. 4

    The Potential Role of Primary Care in Case Detection/Screening of Primary Aldosteronism.

    Kline GA, Prebtani APH, Leung AA, Schiffrin EL

    American journal of hypertension 2017; (30(12)):1147-1150 doi:10.1093/ajh/hpx064.

    PMID: 28992276
  5. 5

    Pathogenesis of primary aldosteronism.

    Parra Ramírez P, Martín Rojas-Marcos P

    Vitamins and hormones 2026; (130()):27-41 doi:10.1016/bs.vh.2025.08.004.

    PMID: 41638802
  6. 6

    The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study.

    Brown JM, Robinson-Cohen C, Luque-Fernandez MA, et al.

    Annals of internal medicine 2017; (167(9)):630-641 doi:10.7326/M17-0882.

    PMID: 29052707
  7. 7

    The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study.

    Brown JM, Siddiqui M, Calhoun DA, et al.

    Annals of internal medicine 2020; (173(1)):10-20 doi:10.7326/M20-0065.

    PMID: 32449886
  8. 8

    Autonomous Aldosterone Secretion as a Subclinical Form of Primary Aldosteronism: Pathogenesis and Clinical Significance.

    Kmieć P, Sworczak K

    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2022; (130(1)):7-16 doi:10.1055/a-1556-7784.

    PMID: 34614533
  9. 9

    PREVELENCE OF PRIMARY ALDOSTERONISM IN AN URBAN HYPERTENSIVE POPULATION.

    Galati SJ, Cheesman KC, Springer-Miller R, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2016; (22(11)):1296-1302 doi:10.4158/E161332.OR.

    PMID: 27893293
  10. 10

    Primary Hyperaldosteronism: Epidemiology, Diagnosis, and Clinical Associations.

    Savvidis C, Milionis C, Pachi A, et al.

    Epidemiologia (Basel, Switzerland) 2026; (7(2)) doi:10.3390/epidemiologia7020032.

    PMID: 41873981
  11. 11

    The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

    Funder JW, Carey RM, Mantero F, et al.

    The Journal of clinical endocrinology and metabolism 2016; (101(5)):1889-916 doi:10.1210/jc.2015-4061.

    PMID: 26934393
  12. 12

    Diagnosing and Managing Primary Aldosteronism in Hypertensive Patients: a Case-Based Approach.

    Carey RM

    Current cardiology reports 2016; (18(10)):97 doi:10.1007/s11886-016-0774-1.

    PMID: 27566330
  13. 13

    Broadening Primary Aldosteronism Screening: Alignment Across Contemporary Guidelines.

    Owei L, Wachtel H, Cohen JB

    Hypertension (Dallas, Tex. : 1979) 2026; (83(5)):e26228 doi:10.1161/HYPERTENSIONAHA.125.26228.

    PMID: 41645899
  14. 14

    Prevalence of Hypokalemia and Primary Aldosteronism in 5100 Patients Referred to a Tertiary Hypertension Unit.

    Burrello J, Monticone S, Losano I, et al.

    Hypertension (Dallas, Tex. : 1979) 2020; (75(4)):1025-1033 doi:10.1161/HYPERTENSIONAHA.119.14063.

    PMID: 32114853
  15. 15

    SFE/SFHTA/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic steps.

    Douillard C, Houillier P, Nussberger J, Girerd X

    Annales d'endocrinologie 2016; (77(3)):192-201.

    PMID: 27177498
  16. 16

    Diagnosis and treatment of primary aldosteronism: practical clinical perspectives.

    Young WF

    Journal of internal medicine 2019; (285(2)):126-148 doi:10.1111/joim.12831.

    PMID: 30255616

This page is for informational purposes only and does not constitute medical advice. Do not stop or change blood pressure medicines for aldosterone testing without guidance from your clinician.